This website is intended for Medical Professionals only. By using this site you confirm that you are a healthcare professional.

News
Statins Overprescribed for Primary Prevention Taking cholesterol-lowering drugs, or statins, as a preventive ... (06 Dec 2018)
Babies kicking in the womb are creating a ... The kicks a mother feels from her unborn child may allow the ... (04 Dec 2018)
Many diseases increase the risks of hip ... Parkinson's disease, osteoarthritis, rheumatic diseases, ... (04 Dec 2018)
Graphic warnings snuff out cigarettes’ ... New research from Cornell University suggests graphic warning ... (04 Dec 2018)
Science Proves Vaccines are Helpful, Not ... As more and more parents buy into the belief that vaccines cause ... (04 Dec 2018)
Friday, 10 November 2017 22:56

The re-emergence of lymphogranuloma venereum in Europe, a Maltese case

Written by
Rate this item
(0 votes)

K Muscat, V Padovese, Genito-Urinary Medicine Clinic, Mater Dei Hospital, Malta


Lymphogranuloma venereum (LGV) is a sexually transmitted infection (STI) caused by Chlamydia trachomatis serovars L1-L3, L2 being the most common. Prior to 2003, LGV was considered a tropical disease and thus, generally sporadic and ‘imported’ into Europe from endemic countries. In recent years LGV has been consistently on the rise, especially in HIV positive men who have sex with men (MSM) with high-risk sexual behaviour, and several EU countries have reported an increase in the incidence of LGV. Current guidelines recommend screening all MSM who give a history of receptive anal intercourse in the previous 6 months for anorectal Chlamydia trachomatis infection. MSM who result positive for anorectal infection, should subsequently be screened for LGV. Approximately 25% of LGV infections can be asymptomatic and may represent a missed pool of undiagnosed LGV. In April 2016, the GU Clinic in Malta started screening all MSM who test positive for rectal Chlamydia trachomatis for LGV, irrespective of HIV status. The test consists of a rectal PCR swab for the detection of L1, L2, L3 Chlamydia trachomatis serovars. To date, there have been 60 documented diagnoses of rectal Chlamydia trachomatis, with one patient testing positive for LGV, serovar L2. This is the first documented LGV case in Malta in a HIV negative MSM on Pre-Exposure Prophylaxis (PrEP). As with other STIs, education on prevention, a high index of suspicion and early diagnosis and treatment are essential to prevent late, irreversible complications such as anal fistulae and strictures. From a public health perspective, surveillance and notification of LGV cases are essential to provide a clearer picture on its emergence in Europe.

Click here to download the programme and register to attend Dermfest 2017

Read 1849 times

Jamesco News

Has no content to show!

GSK

Vivian

TheSynapse Magazines

Latest news

Highlights

  • CLINICS AVAILABLE AT RATIONAL PHARMACY

    CLINICS AVAILABLE  AT RATIONAL PHARMACY , VALLEY ROAD,  B'KARA FOR CONSULTANTS .  GENERAL PRACTITIONER REQUIRED MORNINGS AND AFTERNOONS.

    Written on November 19, 2018
  • WASP Course in Bahrain

    WASP Course, led by Prof Victor Grech and Prof Charles Savona Ventura, has recently organised a course in Bahrain. 

    Written on April 24, 2018 Read more...

Join

Connect with other Medical Professionals on fb in a closed facebook group

Login

Top
We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…